Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT07845240

Efficacy of Balloon Tamponade in Post-partum Hemorrhage Within 24 Hours After Delivery

Conditions: Postpartum Hemorrhage

Sex: Female
Ages: 18 Years – 35 Years
Healthy volunteers: No
Enrollment: 121
Sponsor: Aziz Fatimah Medical & Dental College, Faisalabad

Location: Aziz Fatima hospital Faisalābad Punjab Province

Summary

Postpartum hemorrhage (PPH) is a major cause of maternal death, especially in developing countries like Pakistan where it accounts for up to 34% of maternal deaths. When bleeding after delivery does not stop with medicines like oxytocin and uterine massage, a low-cost method called balloon tamponade can be life-saving. This study titled "Efficacy of Balloon Tamponade in Post-partum Hemorrhage within 24 Hours After Delivery" will be conducted by Dr. Maryam Aslam (PGR Gynecology and Obstetrics) under supervision of Prof. Dr. Raheela Farhat at Aziz Fatima Hospital, Faisalabad. The objective is to determine the efficacy of intrauterine balloon tamponade (condom catheter balloon) in controlling primary PPH. Efficacy is defined as successful control of bleeding within six hours of balloon insertion without need for additional surgery, confirmed by absence of active vaginal bleeding, a contracted uterine fundus, and stable maternal condition after removal of the balloon. The results will help promote a simple, effective procedure that can even be used by primary health care workers to reduce maternal mortality.

Eligibility Criteria

Inclusion Criteria: * Age 18-35 years * Having gestational age between 31 to 41 weeks * Having PPH (Primary postpartum hemorrhage unresponsive to uterotonics) Exclusion Criteria: * Patient who has Obstetric hemorrhage (Antepartum Hemorrhage) \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07845240). StuddyBuddy aggregates publicly available trial information.